Edward M. Kaye M.D., Director at Stoke Therapeutics, Inc. (STOK), sold 12,567 shares at $32.01 ($403K) on 2026-08-18, disclosed to the SEC on 2026-08-18.
Open-market sale of $403k STOK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.01 | 11,930 | $382K | 94.9% |
| 2 | $32.47 | 637 | $21K | 5.1% |
| Total | $32.03 avg | 12,567 | $403K | 100% |
| Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |
| CYTK | SELL | 2025-12-02 | $3.7M | — | Filing → |